Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19538232 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Investigating the Incretin Effect in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Oral Glucose Tolerance test (75g 2-hour);   Drug: Modified Oral Glucose Tolerance Test (50g 4-hours);   Drug: Matched isoglycemic clamp;   Drug: Hyperglycemic clamp with concurrent GLP-1 infusion;   Drug: Hyperglycemic Clamp with concurrent GIP infusion;   Drug: Hyperglycemic clamp with placebo infusion;   Other: Liquid Meal Test (Carbohydrate-rich);   Other: Liquid Meal Test (Fat-rich);   Other: Liquid Meal Test (Mixed);   Device: Continuous Glucose Monitoring

Indicates status has not been verified in more than two years